Volume 17, Number 1—January 2011
Dispatch
Foreign Travel and Decreased Ciprofloxacin Susceptibility in Salmonella enterica Infections
Table
Relationship between nontyphoidal Salmonella enterica serovar, phage type, nalidixic acid resistance, and history of foreign travel, Liverpool, UK, 2003–2009*
Serovar |
Total no. (%) patient isolates |
No. (%) patients with foreign travel history |
No. (%) patients with nalidixic acid–resistant isolate |
No. (%) patients with foreign travel history and nalidixic acid–resistant isolate |
All | 492 (100.0) | 110 (22.4) | 103 (20.9) | 35 (31.8) |
Enteritidis PT1 | 53 (10.8) | 16 (30.2) | 36 (67.9) | 9 (56.3) |
Enteritidis PT4 | 93 (18.9) | 12 (12.9) | 4 (4.3) | 2 (16.7) |
Enteritidis PT8 | 43 (8.7) | 8 (18.6) | 1 (2.3) | 1 (12.5) |
Enteritidis PT21 | 22 (4.5) | 5 (22.7) | 10 (45.4) | 1 (20.0) |
Enteritidis (other PT) | 104 (21.1) | 13 (12.5) | 16 (15.4) | 3 (23.1) |
Typhimurium | 44 (8.9) | 11 (25.0) | 3 (6.8) | 1 (9.1) |
Newport | 14 (2.8) | 3 (21.4) | 8 (57.1) | 3 (100.0) |
Virchow | 12 (2.4) | 9 (75.0) | 11 (91.7) | 8 (88.9) |
Other | 107 (21.7) | 33 (30.8) | 14 (13.1) | 7 (21.2) |
*PT, phage type.